Article
<i>In vivo</i> correction of cystic fibrosis mediated by PNA nanoparticles
2022-01-28
Abstract excerpt
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We sought to correct the multiple organ dysfunction of the F508del CF-causing mutation using systemic delivery of peptide nucleic acid gene editing technology mediated by biocompatible polymeric nanoparticles. We confirmed phenotypic and genotypic modification in vitro in primary nasal epithelial ce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f4911996-dd34-50dd-bf6d-a63c2635463e
- DOI
- 10.1101/2022.01.28.478191
